Abstract
Background: Gallstone disease as well as gallbladder cancer are more common in women and female sex hormones may be involved in their etiology.
Aim and Methods: To determine whether female sex hormones have a role in the pathogenesis, of gallbladder carcinoma and in its prognosis, we estimated, by enzyme immunoassay, the estrogen and progesterone receptors (ER and PgR) in the gallbladders of 21 patients with gallbladder cancer, 19 patients with cholelithiasis, and 6 patients who underwent incidental removal of essentially normal gallbladder as a component of wider resection.
Results: ER were present in the gallbladder mucosa in all the three groups in proportions which were not significantly different (9/21 in carcinoma, 4/19 in gallstones, and 1/6 normal), whereas the expression of PgR was greater in carcinomas (13/18), less in cholelithiasis (4/12), and absent in normal gallbladders. PgR expression was higher in tumors of lower stage (7/7) and lower in advanced disease stage IV tumors (6/11). PgR expression was associated with better disease stage (p=0.05) and significantly longer overall survival (median survival of 301 d vs 54 d) as well as better survival within the same stage (269 d vs 54 d for stage IV disease, p=0.011). Cox’s regression analysis showed that PgR was an independent risk factor (R=0.2283, p=0.0035).
Conclusions: Our findings suggest that the female sex hormones may have a role in the pathogenesis of gallbladder cancer and that PgR expression has a prognostic significance. We believe that when this relationship is reaffirmed by larger studies, gallbladder cancer may be treated with appropriate sex hormonal manipulation.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Sen U, Sankaranarayanan R, Mandal S, Ramanakumar AV, Parkin DM, Siddiqi M. Cancer patterns in eastern India: the first report of the Kolkata cancer registry. Int J Cancer 2002;100:86–91.
Cubertafond P, Gainant A, Cucchiaro G. Surgical treatment of 724 carcinomas of the gallbladder. Results of the French Surgical Association Survey. Surgery 1994;219:275–280.
Nakamura S, Muro H, Suzuki S. Estrogen and progesterone receptors in gallbladder cancer. Jpn J Surg 1989;19:189–194.
Hendrickse CW, Jones CE, Donovan IA, Neoptolemos JP, Baker PT. Oestrogen and progesterone receptors in colorectal cancer and human colonic cancer cell lines. Br J Surg 1993;80:636–640.
Milgrom E, Baulieu EE. Progesterone in uterus and plasma. I. Binding in rat uterus 105,000 g supernatant. Endocrinology 1970;87:276–287.
Raneletti FO, Plantelli M, Farinon AM, Zanella E, Capelli A. Estrogen and progesterone receptors in the gallbladders from patients with gallstones. Hepatology 1991;14:608–612.
Vyas JJ, Rahalkar C, Kelkar DS, Shinde SR, Mittra I, Redkar A. Observations on estrogen receptor status in Indian population. Tata Memorial Hospital Experience. Indian J Surg 1991;53:435–438.
Costa SD, Lange S, Klinga K, Merkle E, Kaufmann M. Factors influencing the prognostic role of oestrogen and progesterone receptor levels in breast cancer-results of the analysis of 670 patients with 11 years of follow-up. Eur J Cancer 2002;38:1329–1334.
Sellers TA, Davis J, Cerhan JR, et al. Interaction of waist/hip ratio and family history on the risk of hormone receptordefined breast cancer in a prospective study of postmenopausal women. Am J Epidemiol 2002;155:225–233.
Malik IA, Abbas Z, Shamsi Z, et al. Immuno-histochemical analysis of estrogen receptors on the malignant gallbladder tissue. J Pak Med. Assoc 1990;48:123–126.
Horwitz KB, McGuire WL. Estrogen control of progesterone receptor in human breast cancer. Correlation with nuclear processing of estrogen receptor. J Biol Chem. 1978;253:2223–2228.
Uhler ML, Marks JW, Voigt BJ, Judd HL: Comparison of the impact of transdermal versus oral estrogens on biliary markers of gallstone formation in postmenopausal women. J Clin Endocrinol Metab 1998;83:410–414.
Tierney S, Nakeeb A, Wong O, et al. Progesterone alters biliary flow dynamics. Ann Surg 1999;229:205–209.
Waliszewski P, Blaszczyk M, Wolinska-Witort E, Drews M, Snochowski M, Hurst RE. Molecular study of of sex steroid receptor gene expression in human colon and in colorectal carcinomas. J Surg Oncol 1997;64:3–11.
Chung MA, Wazer D, Cady B. Contemporary management of breast cancer. Obstet Gynecol Clin North Am. 2002;29:173–188.
Martin PM, Rolland PH, Gammerre M, Serment H, Toga M. Estradiol and progesterone receptors in normal and neoplastic endometrium: Correlations between receptors, histopathological examinations and clinical responses under progestin therapy. Int J Cancer 1979;23:321–329.
Geisler JP, Wiemann MC, Miller GA, Zhou Z, Geisler HE. Estrogen and progesterone receptors in malignant mixed mesodermal tumors of the ovary. J Surg Oncol 1995;59:45–47.
Ko CY, Schmit P, Cheng L, Thompson JE. Estrogen receptors in gallbladder cancer: detection by an improved immunohistochemical assay. Am Surg 1995; 61:930–933.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Baskaran, V., Vij, U., Sahni, P. et al. Do the progesterone receptors have a role to play in gallbladder cancer?. Int J Gastrointest Canc 35, 61–68 (2005). https://doi.org/10.1385/IJGC:35:1:061
Issue Date:
DOI: https://doi.org/10.1385/IJGC:35:1:061